The EU has concluded a deal with BioNTech/Pfizer for up to 1.8 billion extra doses of its COVID-19 vaccine, European Commission chief Ursula von der Leyen said on Saturday.
“Happy to announce that the EU Commission has just approved a contract for guaranteed 900 million doses (+900 million options) with BioNTech/Pfizer for 2021-2023,” she tweeted from an EU summit in Portugal.
“Other contracts and other vaccine technologies will follow,” she promised.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
EU seals deal for up to 1.8 bn extra BioNTech/Pfizer doses (2021, May 8)
retrieved 8 May 2021
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.